India has authorized two COVID-19 vaccines on Sunday to begin its large scale inoculation program, however, the country will not permit the export of the Oxford University AstraZeneca vaccine for several months.
The ban on the export of newly approved vaccines means that poorer nations will have to wait for several months before they could receive their first shots.
Meanwhile, permission was permitted for Bharat Biotechâs shot for restricted use in the âpublic interest as an abundant precaution in clinical trial mode, especially in the context of infection by mutant strains.â
However, Dr. Gagandeep Kang, an infectious disease expert at the Christian Medical College at Vellore, said that the claim that the vaccine could help fight against the mutant variant of the virus was only âhypothetical” as they weren’t able to provide any concrete evidence.
Indian regulators are still considering approvals for other vaccines, including Pfizer’s.
Article (c) Fourth Estate – All Rights Reserved.
Provided by FeedSyndicate.com